Cargando…
Listeria-Vectored Multiantigenic Tuberculosis Vaccine Enhances Protective Immunity against Aerosol Challenge with Virulent Mycobacterium tuberculosis in BCG-Immunized C57BL/6 and BALB/c Mice
Mycobacterium tuberculosis infects approximately one-third of the world's population, causing active tuberculosis (TB) in ~10 million people and death in ~1.5 million people annually. A potent vaccine is needed to boost the level of immunity conferred by the current Mycobacterium bovis BCG vacc...
Autores principales: | Jia, Qingmei, Masleša-Galić, Saša, Nava, Susana, Horwitz, Marcus A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239278/ https://www.ncbi.nlm.nih.gov/pubmed/35642945 http://dx.doi.org/10.1128/mbio.00687-22 |
Ejemplares similares
-
Listeria-vectored multi-antigenic tuberculosis vaccine protects C57BL/6 and BALB/c mice and guinea pigs against Mycobacterium tuberculosis challenge
por: Jia, Qingmei, et al.
Publicado: (2022) -
Drug regimens identified and optimized by output-driven platform markedly reduce tuberculosis treatment time
por: Lee, Bai-Yu, et al.
Publicado: (2017) -
Lung stiffness of C57BL/6 versus BALB/c mice
por: Rojas-Ruiz, Andrés, et al.
Publicado: (2023) -
Evaluation of Susceptibility and Innate Immune Response in C57BL/6 and BALB/c Mice During Candida albicans Endophthalmitis
por: Rottmann, Bruce G., et al.
Publicado: (2020) -
Distinct iron homeostasis in C57BL/6 and Balb/c mouse strains
por: Saha, Piu, et al.
Publicado: (2020)